Image-Guided Radiation Therapy Market Report 2026

Image-Guided Radiation Therapy Market Overview

• Image-Guided Radiation Therapy market size has reached to $1.99 billion in 2025 • Expected to grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.4% • Growth Driver: Rising Cancer Incidence Fuels Growth in the Image-Guided Radiation Therapy Market • Market Trend: Leading Companies Drive Innovation In The Image-Guided Radiation Therapy Market • North America was the largest region in 2025.

What Is Covered Under Image-Guided Radiation Therapy Market?

Image-guided radiation therapy (IGRT) refers to a medical technique used in the field of radiation oncology to deliver precise and targeted radiation treatment to cancerous tumors. It is used to reduce treatment toxicity and enable the safe delivery of more precise radiation doses to patients suffering from cancer. The main product types of image-guided radiation therapy are 4D gating and 4D RT, linear accelerator (linac), pet and MRI-guided radiation therapy, portal imaging, and CT scanning. 4D Gating and 4D RT refer to a medical technique that involves the monitoring and synchronization of a patient's respiratory or cardiac motion with the delivery of radiation or imaging to ensure that the treatment or imaging is accurately targeted. The various procedures involved are intensity-modulation radiation therapy, 3D conformal radiation therapy, stereotactic therapy, proton beam therapy, and particle therapy, which consists of applications such as lung cancer, prostate cancer, head and neck cancer, gynecological cancer, gastrointestinal cancer, and others, and end-users are hospitals and independent radiotherapy centers.

What Is The Image-Guided Radiation Therapy Market Growth Forecast?

The image-guided radiation therapy market size is expected to see steady growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to integration of AI in treatment planning and imaging, growing demand for non-invasive cancer treatments, rising investments in advanced radiotherapy centers, increasing adoption of proton and particle therapy, expanding access to cancer care in emerging markets. Major trends in the forecast period include increasing adoption of precision radiation delivery, growing integration of real-time imaging in radiotherapy, rising demand for personalized cancer treatment planning, expansion of stereotactic and proton-based therapies, increasing focus on reducing radiation-induced toxicity.

Global Image-Guided Radiation Therapy Market Segmentation

1) By Product Type: 4D Gating And 4D RT, Linear Accelerator (LINAC), PET And MRI Guided Radiation Therapy, Portal Imaging, CT Scanning 2) By Procedure: Intensity-Modulation Radiation Therapy, 3D Conformal Radiation Therapy, Stereotactic Therapy, Proton Beam Therapy, Particle Therapy 3) By Application: Lung Cancer, Prostate Cancer, Head And Neck Cancer, Gynecological Cancer, Gastrointestinal Cancer, Other Applications 4) By End User: Hospitals, Independent Radiotherapy Centers Subsegments: 1) By 4D Gating and 4D RT: 4D Gating Systems, 4D Radiation Therapy Systems 2) By Linear Accelerator (LINAC): Conventional LINAC Systems, Advanced LINAC Systems 3) By PET And MRI Guided Radiation Therapy: PET/CT Guided Radiation Therapy, MRI Guided Radiation Therapy 4) By Portal Imaging: Electronic Portal Imaging, Conventional Portal Imaging 5) By CT Scanning: CT Imaging For Radiation Therapy Planning, Cone Beam CT For Radiation Therapy

What Is The Driver Of The Image-Guided Radiation Therapy Market?

The increasing incidence of cancer is expected to propel the growth of the image-guided radiation therapy market going forward. Cancer refers to the uncontrolled proliferation and dissemination of abnormal cells within the body. Image-guided radiation therapy (IGRT) is used for cancer treatment due to its ability to provide precise and accurate radiation to cancer cells while minimizing damage to healthy tissue and reducing side effects. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, reported that in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing incidence of cancer is driving the growth of the image-guided radiation therapy industry going forward.

Key Players In The Global Image-Guided Radiation Therapy Market

Major companies operating in the image-guided radiation therapy market are Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Varian Medical Systems Inc., Elekta AB, Canon Medical Systems R&D (Dalian) Co. Ltd., Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Standard Imaging Inc., CIVCO Radiotherapy Inc., RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation, RefleXion Medical Inc.

Global Image-Guided Radiation Therapy Market Trends and Insights

Major companies operating in the image-guided radiation therapy market are focusing on technological advancements such as Cenos, which is an online adaptive therapy option for radiotherapy treatments. Cenos offers healthcare professionals the ability to promptly and effectively modify a radiation therapy treatment plan if needed while the patient is still undergoing treatment. For instance, in October 2023, Accuray Incorporated, a US-based manufacturer of radiation therapy systems, in partnership with Limbus AI, a Canada-based artificial intelligence company, launched the Cenos platform for its Radixact System. It is a state-of-the-art treatment delivery system that offers compromise-free capabilities to treat a wide range of cancer cases, including breast, prostate, lung, and head and neck cancers, as well as complex treatments such as total marrow irradiation. It has unique features, including a high-speed multileaf collimator, a fully integrated platform, and the Tomo C platform. Moreover, this therapy option provides healthcare providers with the option to carry out an online adjustment of their treatment plan to accommodate any changes that may arise between treatment sessions.

What Are Latest Mergers And Acquisitions In The Image-Guided Radiation Therapy Market?

In October 2023, Elekta AB, a Sweden-based provider of precision radiotherapy and brachytherapy systems, acquired the Xoft business from iCAD Inc. for approximately $5.5 million. With this acquisition, Elekta sought to expand its technological offerings by integrating Xoft’s low-energy X-ray electronic brachytherapy (eBx) system, thereby broadening its radiation-therapy portfolio and enhancing access to intra-operative and minimally shielded treatment options. Xoft is a US-based company that specializes in providing Axxent eBx System, which delivers localized radiation via a miniaturized X-ray source for a variety of cancer indications including breast, skin, gynecological, and brain cancers.

Regional Outlook

North America was the largest region in the image-guided radiation therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Image-Guided Radiation Therapy Market?

The image-guided radiation therapy market includes revenues earned by entities by providing treatment using various imaging technological services such as positron emission tomography, 2D radiotherapy technology, and 3D radiotherapy technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The image-guided radiation therapy market consists of sales of cone-beam imaging systems, immobilization devices, ultrasound imaging, adaptive radiation therapy systems, and cameras. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Image-Guided Radiation Therapy Market Report 2026?

The image-guided radiation therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the image-guided radiation therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.